Name : BMP5 Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN7970475674
| Long name | BMP5 Primary Polyclonal Antibody |
| Also known as | BMP5 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | BMP5 |
| Specificity | This is a highly specific antibody against BMP5 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 330-380/454 |
| Subcellular location | Secreted |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human BMP5 |
| Gene ID number | 653 |
| Swiss Prot | P22003 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site, Jul 2008], The superfamily includes large families of growth and differentiation factors, These proteins are synthesized as prepropeptides, This gene is differentially regulated during the formation of various tumors, This protein may act as an important signaling molecule within the trabecular meshwork and optic nerve head, [provided by RefSeq, and may play a potential role in glaucoma pathogenesis, and then processed into dimeric proteins, cleaved, This gene encodes a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | BMP-5, BMP5, Bone morphogenetic protein 5 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | BMP5 |
| Short name | BMP5 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | bone morphogenetic protein 5 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | BMP receptor binding, BMP5 and IDBG-91207 and ENSG00000112175 and 653, BT, Bmp5 and IDBG-185557 and ENSMUSG00000032179 and 12160, Extracellular, this GO :0001501 and skeletal system development and biological process this GO :0001503 and ossification and biological process this GO :0003323 and type B pancreatic cell development and biological process this GO :0005125 and cytokine activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005575 and cellular component and cellular component this GO :0005615 and extracellular space and cellular component this GO :0007389 and pattern specification process and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0010719 and negative regulation of epithelial to mesenchymal transition and biological process this GO :0010862 and positive regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0010894 and negative regulation of steroid biosynthetic process and biological process this GO :0030539 and male genitalia development and biological process this GO :0031988 and membrane-bounded vesicle and cellular component this GO :0032348 and negative regulation of aldosterone biosynthetic process and biological process this GO :0040007 and growth and biological process this GO :0043569 and negative regulation of insulin-like growth factor receptor signaling pathway and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0050679 and positive regulation of epithelial cell proliferation and biological process this GO :0051216 and cartilage development and biological process this GO :0070700 and BMP receptor binding and molecular function this GO :0071676 and negative regulation of mononuclear cell migration and biological process this GO :1900006 and positive regulation of dendrite development and biological process this GO :1902042 and negative regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :2000065 and negative regulation of cortisol biosynthetic process and biological process this GO :2000105 and positive regulation of DNA-dependent DNA replication and biological process, this GO :0005125: cytokine activity, this GO :0005125: cytokine activity and also this GO :0005515: protein binding and also this GO :0008083: growth factor activity and also this GO :0070700: BMP receptor binding, this GO :0005515: protein binding, this GO :0008083: growth factor activity, this GO :0070700: BMP receptor binding, 29026 and IDBG-628704 and ENSBTAG00000012870 and 507682, bone morphogenetic protein 5 |
| Identity | 1072 |
| Gene | BMP5 |
| Long gene name | bone morphogenetic protein 5 |
| Locus | 6p12, 1 |
| Discovery year | 1991-06-05 |
| Entrez gene record | 653 |
| Pubmed identfication | 1427904 11580864 |
| Classification | Endogenous ligands Bone morphogenetic proteins |
| Havana BLAST/BLAT | OTTHUMG00000014903 |